Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 168

1.

Persistence of immunity to tick-borne encephalitis after vaccination and natural infection.

Baldovin T, Mel R, Bertoncello C, Carpenè G, Soppelsa F, Giliberti A, Baldo V.

J Med Virol. 2012 Aug;84(8):1274-8. doi: 10.1002/jmv.23313.

PMID:
22711356
2.

Long-term persistence of tick-borne encephalitis antibodies in children 5 years after first booster vaccination with Encepur Children.

Wittermann C, Petri E, Zent O.

Vaccine. 2009 Mar 4;27(10):1585-8. doi: 10.1016/j.vaccine.2008.12.057. Epub 2009 Jan 20.

PMID:
19162115
3.

Long-term immunity after vaccination against tick-borne encephalitis with Encepur using the rapid vaccination schedule.

Beran J, Douda P, Gniel D, Zent O.

Int J Med Microbiol. 2004 Apr;293 Suppl 37:130-3.

PMID:
15146994
4.

Persistence of protective immunity following vaccination against tick-borne encephalitis--longer than expected?

Rendi-Wagner P, Kundi M, Zent O, Dvorak G, Jaehnig P, Holzmann H, Mikolasek A, Kollaritsch H.

Vaccine. 2004 Jul 29;22(21-22):2743-9.

PMID:
15246606
5.

TBE booster immunization in adults--first experience with a new tick-borne encephalitis (TBE) vaccine, free of protein-derived stabilizer.

Zent O, Schwarz TF, Plentz A, Banzhoff A, Jilg W.

Int J Med Microbiol. 2004 Apr;293 Suppl 37:134-8.

PMID:
15146995
6.

Serological response to tick-borne encephalitis (TBE) vaccination in the elderly--results from an observational study.

Jílková E, Vejvalková P, Stiborová I, Skorkovský J, Král V.

Expert Opin Biol Ther. 2009 Jul;9(7):797-803. doi: 10.1517/14712590903066711.

PMID:
19527104
7.

Antibody persistence following booster vaccination against tick-borne encephalitis: 3-year post-booster follow-up.

Rendi-Wagner P, Paulke-Korinek M, Kundi M, Wiedermann U, Laaber B, Kollaritsch H.

Vaccine. 2007 Jun 28;25(27):5097-101. Epub 2007 Feb 20.

PMID:
17555850
8.

TBE booster immunization according to the rapid immunization schedule: are 3-year booster intervals really necessary?

Zent O, Plentz A, Schwarz TF, Frühwein N, Kuhr HB, Broeker M, Banzhoff A, Jilg W.

Vaccine. 2004 Dec 2;23(3):312-5.

PMID:
15530673
9.

Long-term persistence of tick-borne encephalitis antibodies in adults 5 years after booster vaccination with Encepur Adults.

Plentz A, Jilg W, Schwarz TF, Kuhr HB, Zent O.

Vaccine. 2009 Feb 5;27(6):853-6. doi: 10.1016/j.vaccine.2008.11.082. Epub 2008 Dec 9.

PMID:
19071180
10.

Delayed humoral immunity in a patient with severe tick-borne encephalitis after complete active vaccination.

Kleiter I, Jilg W, Bogdahn U, Steinbrecher A.

Infection. 2007 Feb;35(1):26-9.

PMID:
17297586
11.

Seropersistence of tick-borne encephalitis antibodies, safety and booster response to FSME-IMMUN 0.5 ml in adults aged 18-67 years.

Loew-Baselli A, Poellabauer EM, Pavlova BG, Fritsch S, Koska M, Bobrovsky R, Konior R, Ehrlich HJ.

Hum Vaccin. 2009 Aug;5(8):551-6.

PMID:
19430202
12.

Kinetics of the immune response after primary and booster immunization against tick-borne encephalitis (TBE) in adults using the rapid immunization schedule.

Zent O, Jilg W, Plentz A, Schwarz TF, Frühwein N, Kuhr HB, Banzhoff A.

Vaccine. 2003 Dec 1;21(32):4655-60.

PMID:
14585672
13.

Five year follow-up after primary vaccination against tick-borne encephalitis in children.

Wittermann C, Izu A, Petri E, Gniel D, Fragapane E.

Vaccine. 2015 Apr 8;33(15):1824-9. doi: 10.1016/j.vaccine.2015.02.038. Epub 2015 Feb 26.

PMID:
25728316
14.

Tick-born encephalitis (TBE) vaccination in children: advantage of the rapid immunization schedule (i.e., days 0, 7, 21).

Schoendorf I, Ternak G, Oroszlàn G, Nicolay U, Banzhoff A, Zent O.

Hum Vaccin. 2007 Mar-Apr;3(2):42-7. Epub 2007 Mar 22.

PMID:
17297298
15.

Immunogenicity of delayed TBE-vaccine booster.

Askling HH, Vene S, Rombo L, Lindquist L.

Vaccine. 2012 Jan 11;30(3):499-502. doi: 10.1016/j.vaccine.2011.11.061. Epub 2011 Nov 26.

PMID:
22122857
16.

Vaccination against tick-borne encephalitis--distant evaluation.

Bobrowska E, Grzeszczuk A, Prokopowicz D.

Rocz Akad Med Bialymst. 1996;41(1):44-50.

PMID:
8673804
17.

Study of the serological response after vaccination against tick-borne encephalitis in Sweden.

Vene S, Haglund M, Lundkvist A, Lindquist L, Forsgren M.

Vaccine. 2007 Jan 4;25(2):366-72. Epub 2006 Aug 2.

PMID:
16959384
18.

Decreased antibody titers and booster responses in tick-borne encephalitis vaccinees aged 50-90 years.

Weinberger B, Keller M, Fischer KH, Stiasny K, Neuner C, Heinz FX, Grubeck-Loebenstein B.

Vaccine. 2010 Apr 30;28(20):3511-5. doi: 10.1016/j.vaccine.2010.03.024. Epub 2010 Mar 21.

PMID:
20332047
19.

Anti-tick-borne encephalitis (TBE) virus neutralizing antibodies dynamics in natural infections versus vaccination.

Remoli ME, Marchi A, Fortuna C, Benedetti E, Minelli G, Fiorentini C, Mel R, Venturi G, Ciufolini MG.

Pathog Dis. 2015 Mar;73(2):1-3. doi: 10.1093/femspd/ftu002. Epub 2014 Dec 4.

PMID:
25722483
20.

Booster vaccinations against tick-borne encephalitis: 6 years follow-up indicates long-term protection.

Paulke-Korinek M, Rendi-Wagner P, Kundi M, Laaber B, Wiedermann U, Kollaritsch H.

Vaccine. 2009 Nov 23;27(50):7027-30. doi: 10.1016/j.vaccine.2009.09.068. Epub 2009 Sep 26.

PMID:
19786143

Supplemental Content

Support Center